Geron | GERN - Current Assets

Stock Price
1.75
Daily Change
-0.14 -7.18%
Monthly
27.37%
Yearly
-26.99%
Q1 Forecast
1.82

Geron reported $522.34M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Amgen USD 29.06B 1.17B Dec/2025
Bio Techne USD 637.43M 27.92M Dec/2025
Cassava Sciences USD 108.91M 5.91M Sep/2025
Cytokinetics USD 977.35M 90.81M Sep/2025
Esperion Therapeutics USD 360.46M 17.87M Sep/2025
Exelixis USD 1.44B 41.03M Dec/2025
Genmab DKK 3.91B 127M Jun/2025
Geron USD 522.34M 16.75M Sep/2025
Gilead Sciences USD 19.89B 1.05B Dec/2025
Incyte USD 5.02B 746.01M Dec/2025
MacroGenics USD 232.09M 27.15M Sep/2025
Novartis USD 28.2B 2.26B Sep/2025
Novavax USD 974.59M 55.08M Sep/2025